Reverse genetics

Reverse genetics is a specialized method used in molecular genetics to determine the function of specific genes. While classical forward genetics begins with a visible trait or phenotype and searches for its genetic cause, reverse genetics works in the opposite direction. Researchers start with a known genetic sequence and manipulate it to observe the resulting physical or biological effects on an organism. This approach is vital because modern automated DNA sequencing allows scientists to identify large amounts of genomic data very quickly. Often, these sequences are discovered long before their actual biological purpose is understood. By using reverse genetics, scientists can finally connect a specific sequence to its role in a living system.

To discover a gene's function, researchers must engineer changes or disruptions within the DNA. One common method is a gene knockout, where a gene is rendered non-functional. This can be achieved through gene targeting via homologous recombination. In certain organisms like yeast, mice, and the moss Physcomitrella patens, this process is highly efficient. In yeast, researchers have even created directed deletions for every non-essential gene in the genome. Another method is site-directed mutagenesis, which is a sophisticated technique for making precise changes. Scientists might alter regulatory regions in a gene's promoter or make subtle codon changes within the open reading frame. This helps them identify which specific amino acid residues are necessary for a protein to function correctly.

Researchers also utilize techniques that offer more control over when and where a gene is active. For example, they can use conditional alleles, which allow a gene to function normally until it is specifically activated. This is often done by "knocking in" recombinase sites, such as lox or frt sites, into the DNA. Once a specific recombinase like Cre or Flp is induced through heat shock or chemical treatments, the target gene is deleted. Another approach is TILLING, which combines chemical mutagenesis using ethyl methanesulfonate (EMS) with sensitive DNA screening. This allows scientists to identify specific point mutations within a target gene. These various methods allow for a deep, systematic exploration of how genetic changes impact an organism's development.

Beyond permanent DNA changes, scientists can use gene silencing to achieve a temporary effect known as a gene knockdown. Unlike a knockout, which is a permanent change to the DNA, knockdown methods do not mutate the genome. One major technique is RNA interference (RNAi), which uses double-stranded RNA to trigger the cell to degrade target messenger RNA (mRNA). This process relies on cellular components like Dicer proteins and the RISC complex to function. An alternative is the use of Morpholino antisense oligos. These molecules bind to and block target mRNA without needing cellular proteins or accelerating degradation. Morpholinos are highly versatile, working in environments ranging from simple test tubes to complex animal models.

Reverse genetics is also a powerful tool in the field of virology. It enables the recovery of full-length infectious viruses that contain specific, desired mutations or insertions. Technologies like the circular polymerase extension reaction (CPER) have been used to generate infectious cDNA for viruses like the Kunjin virus. CPER has also been successful in generating positive-sense RNA viruses, including SARS-CoV-2, the virus that causes COVID-19. By manipulating viral genomes in this way, scientists can study how viruses behave both in a controlled lab setting (in vitro) and within a living host (in vivo). This capability is essential for understanding viral infection and developing countermeasures.

One of the most significant applications of reverse genetics is the synthesis of attenuated vaccines. An attenuated vaccine contains a live virus that has been weakened so it cannot cause serious disease. Instead of using traditional methods like killing a virus with heat or chemicals—known as inactivated vaccines—reverse genetics allows for the engineering of novel genotypes. Scientists can combine genes from a current, circulating virus strain with genes from a previously weakened master strain. This creates a vaccine that is highly similar to the actual threat but lacks its dangerous potency. This method is particularly useful for the influenza A virus, which requires constant updates due to high antigenic variation.

To produce an influenza vaccine, scientists often use an eight-plasmid system to synthesize the virus. Because the influenza A genome consists of eight RNA segments, researchers use six plasmids from an attenuated master strain and two plasmids from the current wild-type strain. Specifically, the fourth and sixth segments, which encode the hemagglutinin (HA) and neuraminidase (NA) proteins, are taken from the circulating virus. These proteins are chosen because they vary greatly between strains. The plasmids include restriction sites for gene insertion, antibiotic resistance genes for selection, and promoters like human pol 1 and pol 2 to drive transcription. When these plasmids are co-transfected into a target cell, such as a chicken egg, they create a defective but effective vaccine strain. This process is much faster than older methods and results in a vaccine with higher immunogenicity, meaning it triggers a stronger immune response.